Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
奥克瑞珠单抗治疗活动性原发性进展型多发性硬化症患者:临床结果和治疗反应的免疫标志物
期刊:Cells
影响因子:5.2
doi:10.3390/cells11121959
Boziki, Marina; Bakirtzis, Christos; Sintila, Styliani-Aggeliki; Kesidou, Evangelia; Gounari, Evdoxia; Ioakimidou, Aliki; Tsavdaridou, Vasiliki; Skoura, Lemonia; Fylaktou, Asimina; Nikolaidou, Vasiliki; Stangou, Maria; Nikolaidis, Ioannis; Giantzi, Virginia; Karafoulidou, Eleni; Theotokis, Paschalis; Grigoriadis, Nikolaos